Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 15/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.59 |
| ▸ | QPCT | Q16769 | 1/20 | 0.59 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.59 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.59 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.49 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2716739 | 1.00 | CYP11B1 (0.59) | CYP11B1CYP11B2CYP19A1POLBCYP1A2 | |
| SCHEMBL17997350 | 0.82 | CYP11B1 (0.51) | CYP11B1CYP11B2CYP19A1POLBCYP1A2 | |
| SCHEMBL8337928 | 0.82 | TBXAS1 (0.54) | CYP11B1CYP11B2CYP19A1CYP3A4CYP2D6 | |
| SCHEMBL1586517 | 0.81 | CYP11B1 (0.58) | CYP11B1CYP11B2CYP19A1POLBCYP1A2 | |
| SCHEMBL30880299 | 0.80 | ALDH1A1 (0.52) | CYP1A2MAPT | |
| SCHEMBL7475272 | 0.80 | ALDH1A1 (0.52) | CYP1A2MAPT | |
| SCHEMBL14829642 | 0.80 | CYP3A4 (0.55) | CYP19A1CYP3A4CYP2D6TBXAS1CYP2C9 | |
| SCHEMBL12841354 | 0.79 | ALDH1A1 (0.50) | CYP1A2MAPT | |
| SCHEMBL2047732 | 0.78 | CYP11B1 (0.56) | CYP11B1CYP11B2CYP19A1POLBCYP1A2 | |
| SCHEMBL2051043 | 0.76 | CYP11B1 (0.56) | CYP11B1CYP11B2CYP19A1POLBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613459-A | Method for continuously synthesizing silane coupling agent through pipelining and N-heterocyclic carbene complex catalyst used by same | 浙江大学 | 2025-03-14 | — | — | CN | claimed |
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | THE GEORGE WASHINGTON UNIVERSITY (US) | 2025-01-14 | — | — | US | claimed |
| CN-119613459-A | Method for continuously synthesizing silane coupling agent through pipelining and N-heterocyclic carbene complex catalyst used by same | 浙江大学 | 2025-03-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12194448-B2 | Catalysts for the transformation of carbon dioxide and glycerol to formic acid and lactic acid and methods of making the same | MLX, LDHA, CA2 | CYP11B1 2753/4885CYP11B2 2830/4885CYP19A1 2426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.